• Exchange: Tokyo
  • Sector: Health Care
  • Industry: Health Care Facilities/Srvcs
  • Sub-Industry: Health Care Services

JCL Bioassay Corp

+ Add to Watchlist

2190:JP

427.0 JPY 14.0 3.17%

As of 01:59:47 ET on 08/01/2014.

Snapshot for JCL Bioassay Corp (2190)

Open: 436.0 Day's Range: 423.0 - 436.0 Volume: 9,100
Previous Close: 441.0 52wk Range: 360.0 - 750.0 1-Yr Rtn: -22.50%

Stock Chart for 2190

No chart data available.
  • 2190:JP 428.0
  • 1D
  • 1M
  • 1Y
441.0
Interactive 2190 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 2190

Current P/E Ratio (ttm) 23.8016
Estimated P/E(03/2015) -
Relative P/E vs. TPX 1.5313
Earnings Per Share (JPY) (ttm) 17.9400
Est. EPS (JPY) (03/2015) 16.8000
Est. PEG Ratio -
Market Cap (M JPY) 1,781.15
Shares Outstanding (M) 4.17
30 Day Average Volume 11,463
Price/Book (mrq) 1.5766
Price/Sale (ttm) 0.6741
Dividend Indicated Gross Yield -%
Cash Dividend (JPY) -
Dividend Ex-Date 03/27/2015
5 Year Dividend Growth -
Next Earnings Announcement 08/05/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 2190

  • Revenue
  • Net Income (M/JPY)
  • Profit Margin (%)

Company Profile & Key Executives for 2190

JCL Bioassay Corporation provides Clinical and Non-Clinical trial services for pharmaceutical companies. The line of business includes chemical analysis such as determination of drug contents in biological matrices and drug product stability tests.

Kunio MomiyamaPresidentNoriko InoueManaging Director
Takanobu YoshidaDirector
More Company Profile & Key Executives for 2190

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil